Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy.
about
Regional but fatal: Intraperitoneal metastasis in gastric cancerTumor-Specific Peptide, Selected from a Phage Peptide Library, Enhances Antitumor Activity of LactaptinsTRAIL-iRGD is a promising therapeutic agent for gastric cancer treatmentTumor penetrating peptides for improved drug delivery.Cytotoxic T cell responses are enhanced by antigen design involving the presentation of MUC1 peptide on cholera toxin B subunitCoupling Gd‑DTPA with a bispecific, recombinant protein anti‑EGFR‑iRGD complex improves tumor targeting in MRIImproving the targeting of therapeutics with single-domain antibodies.Use of single chain antibody derivatives for targeted drug delivery.Improving paclitaxel pharmacokinetics by using tumor-specific mesoporous silica nanoparticles with intraperitoneal delivery.Anti-EGFR-iRGD recombinant protein conjugated silk fibroin nanoparticles for enhanced tumor targeting and antitumor efficiency.Particle Targeting in Complex Biological Media.Bispecific tumor-penetrating protein anti-EGFR-iRGD efficiently enhances the infiltration of lymphocytes in gastric cancer.Three-dimensional cell culture: A powerful tool in tumor research and drug discovery.A multifunctional metal-organic framework based tumor targeting drug delivery system for cancer therapy.Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment.Access granted: iRGD helps silicasome-encased drugs breach the tumor barrier.A Tumor-Specific Tissue-Penetrating Peptide Enhances the Efficacy of Chemotherapy Drugs in Gastric Cancer.Peptides as drug delivery vehicles across biological barriersFrom 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancerLipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant proteinAnti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatmentFunctionalized Folic Acid-Conjugated Amphiphilic Alternating Copolymer Actively Targets 3D Multicellular Tumour Spheroids and Delivers the Hydrophobic Drug to the Inner Core
P2860
Q28067269-DB695A3F-2492-41F9-9D62-49E793CE84B1Q28553463-E7DCEA29-73C3-463D-A93F-060E26521D63Q33674412-5179BC73-32D7-4992-9B0B-B16F667D9146Q35978545-DB598F74-6321-448C-8A2E-D55C245EED6CQ36544143-BD450C06-7726-4FB3-ACA6-BF062EAB94A3Q36915069-B65D695F-8D3B-41E4-8D96-380E967D4F31Q38675117-3AD502C6-CDDE-47BE-8F7E-81BC70EC9C31Q38850046-7BD0BFF1-5C35-43D1-B167-3FDBC28A2220Q41654060-7DEA98EC-656F-4B38-A409-65DE9CEA17ECQ42082847-F90407CE-A391-4CD8-9AAE-AEC081EF1391Q47794249-9E4298E7-90CD-4278-B837-41F438BD1C4CQ49298130-087B439B-D912-4D5D-A105-6BCF5506F87FQ49553638-5B831253-ACF7-444C-9ACD-F7FA2BA661C3Q50245528-008F6AB7-952E-46C9-ADC5-2E7ED3EF3399Q52362264-BCAFFE28-1C95-4D6B-8EE7-6D1F7AA0D8A0Q54915254-0F0DCCF1-FD01-4FD9-88ED-6F204C6CFF83Q55406473-A8BA0FE7-BD01-424D-BE3B-C8658A40D80AQ56889662-89208269-8F45-45B9-B037-37E880A8956BQ58694509-45853BFF-3641-4E74-892A-D4F2332EB220Q58750896-16EBFE94-3E61-4B2C-ABFF-0E1F6B9E5573Q58781545-97F489C0-0E67-4BD0-892D-952B260A73BBQ58802900-46178C0B-F07F-4DC7-AE8B-EF342F836A78
P2860
Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 December 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor-penetrating peptide fuse ...... ective gastric cancer therapy.
@en
Tumor-penetrating peptide fuse ...... ective gastric cancer therapy.
@nl
type
label
Tumor-penetrating peptide fuse ...... ective gastric cancer therapy.
@en
Tumor-penetrating peptide fuse ...... ective gastric cancer therapy.
@nl
prefLabel
Tumor-penetrating peptide fuse ...... ective gastric cancer therapy.
@en
Tumor-penetrating peptide fuse ...... ective gastric cancer therapy.
@nl
P2093
P2860
P1476
Tumor-penetrating peptide fuse ...... ective gastric cancer therapy.
@en
P2093
Andrew M Blair
Baorui Liu
Leaf Huang
Wuguang Lu
Xinyu Bian
P2860
P304
P356
10.1016/J.JCONREL.2014.12.039
P407
P577
2014-12-30T00:00:00Z